EichorEICHOR
Location: Osaka Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Osaka

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Surgery Plus Chemo Versus Chemoradiotherapy Followed by Surgery Plus Chemo for Locally Recurrent Rectal Cancer
Phase 3 · National Hospital Organization Osaka National Hospital · National Cancer Center Hospital East · NCT04288999Observational Study Protocol: LIVER-R
Phase N/A · AstraZeneca · NCT06252753A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Osaka International Cancer Institute · Eli Lilly and Company · NCT07218380Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Phase 3 · KMU University Hospital · Joseph Broderick, MD · NCT07227246Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT05755386A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
Phase 2 · Investigational Site Number : 3920010 · Sanofi · NCT06867094This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Osaka International Cancer Institute · Pfizer · NCT07028853Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Phase 3 · Osaka City General Hospital · Princess Maxima Center for Pediatric Oncology · NCT05327894A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · Japanese Red Cross Osaka Hospital ( Site 1908) · Merck Sharp & Dohme LLC · NCT06136559Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Osaka Prefectural Hospital Organization Osaka International · Merck Sharp & Dohme LLC · NCT06393374Pembrolizumab and EV With Radiation Therapy for MIBC Patients (PEVRAD)
Phase 2 · Osaka Metropolitan University Hospital · Kyoto University Hospital · NCT05879653This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Osaka International Cancer Institute · Pfizer · NCT06758401A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Phase 3 · Osaka Metropolitan University Hospital · Bristol-Myers Squibb · NCT06929273International Intracranial Dissection Study
Phase N/A · National Cerebral and Cardiovascular Center Osaka · Insel Gruppe AG, University Hospital Bern · NCT02756091A Non-Interventional Study PASS to Characterize Secondary Malignancies of Tcell Origin Following Tisagenlecleucel Therap
Phase N/A · Novartis Investigative Site · Novartis Pharmaceuticals · NCT07378969A Study of Zasocitinib in Adults With Nonsegmental Vitiligo
Phase 2 · Takeda · NCT07108283A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
Phase 3 · Takeda · NCT06671496A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease
Phase 3 · Sanofi · NCT07190196A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · Osaka Metropolitan University Hospital · Hoffmann-La Roche · NCT06793215A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants Wit
Phase 1/Phase 2 · Local Institution - 0017 · Bristol-Myers Squibb · NCT07291076Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Phase 3 · Osaka City General Hospital · PedAL BCU, LLC · NCT05183035A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relaps
Phase 1/Phase 2 · Bristol-Myers Squibb · NCT07325136Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Amgen · NCT07037433Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Phase 3 · Clinical Study Site · Summit Therapeutics · NCT07228832A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advance
Phase 1/Phase 2 · GSK Investigational Site · GlaxoSmithKline · NCT06885034LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Phase 2 · Eli Lilly and Company · NCT07415044A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintena
Phase 3 · Osaka Prefectural Hospital Organization Osaka International · Merck Sharp & Dohme LLC · NCT07216703Exercise Training After Upper Gastrointestinal Cancer Surgery
NA · Kansai Medical University · NCT07561840Study to Assess the Efficacy and Safety of Rina-S in Participants With Advanced Gastrointestinal (GI) Cancers
Phase 2 · Genmab · NCT07539311A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Pati
Phase 2 · Novartis Pharmaceuticals · NCT06581198
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.